EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fungal Microbiota Composition in Inflammatory Bowel Disease Patients: Characterization in Different Phenotypes and Correlation With Clinical Activity and Disease Course

Ignacio Catalán-Serra iD, Silje Thorsvik, Vidar Beisvag, Torunn Bruland iD, David Underhill, Arne Kristian Sandvik, Atle van Beelen Granlund

Inflammatory Bowel Diseases · 03.07.2024 · 30 (7) · 1164-1177

DOI: 10.1093/ibd/izad289 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 16.12.2023. Verfasst von Ignacio Catalán-Serra und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Molecular Inflammation Research, NTNU-Norwegian University of Science and Technology, Trondheim, Norway. Hauptthemen laut MEDLINE: Feces, Phenotype, Mycobiome, Crohn Disease. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is growing evidence of the role of the mycobiome in inflammatory bowel disease (IBD). Variations within phenotypes and activity and with prognosis have been poorly studied.

Methods

A total of 111 individuals were prospectively enrolled: 89 IBD patients (52 ulcerative colitis and 37 Crohn’s disease [CD]) and 22 healthy individuals. Disease characteristics were collected and a fecal calprotectin >100 μg/mg was considered indicative of activity. A subset of patients was followed for 6 ± 2 years. Disease course was designated as either complicated or uncomplicated based on the need of intensified medication and/or surgery. ITS sequencing was performed targeting the ITS1 region.

Results

We found lower Ascomycota/Basidiomycota ratio in IBD. Patients showed a marked increase in Candida dublinensis and Ca albicans and were depleted of Aspergillus rubrobrunneus and Penicillium brevicompactum (P ≤ .001) Saccharomyces was predominant in total colitis and Penicillium in proctitis. Several Penicillium species were depleted in total colitis vs proctitis. Ileal CD patients were enriched in Debaromyces hansenii and depleted of Ca tropicalis (P ≤ .001). Ca albicans was overrepresented in inflammatory (B1) vs fibrostenosing (B2) CD. Ca dublinensis was more abundant in active patients and correlated positively with fecal calprotectin and neutrophil gelatinase-associated lipocalin, while S pastorianus correlated inversely with activity. Ca sake was associated with complicated disease and increased abundance of Cryptococcus carnescens with the need for surgery in CD.

Conclusions

This study shows important differences in the mycobiome in IBD and within phenotypes. Selected fungal species were associated with complicated disease and the need of surgery in CD. This work adds to our understanding of the role of fungi in IBD, with potential clinical implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FecesPhenotypeMycobiomeCrohn DiseaseColitis, UlcerativeHumansFemaleMaleAdultProspective StudiesMiddle AgedCase-Control StudiesInflammatory Bowel DiseasesDisease ProgressionPrognosisLeukocyte L1 Antigen ComplexFungi

Stichwörter der Autor:innen

Crohn's diseasefungiinflammatory bowel diseasemicrobiologymicrobiomemycobiomeprognosisulcerative colitis

Substanzen

Leukocyte L1 Antigen Complex

Autor:innen und Institutionen

  • Centre of Molecular Inflammation Research, NTNU-Norwegian University of Science and Technology, Trondheim, Norway.
  • Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Gastroenterology, Department of Medicine, Levanger Hospital, Nord-Trøndelag Hospital Trust, Levanger, Norway.
  • Department of Gastroenterology and Hepatology, Clinic of Medicine, St. Olav's University Hospital, Trondheim, Norway.
  • Research Division of Immunology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

ORCID-Profile: Ignacio Catalán-Serra, Torunn Bruland

Zitieren

APA

Catalán-Serra, I., Thorsvik, S., Beisvag, V., Bruland, T., Underhill, D., Sandvik, A. K., & Granlund, A. V. B. (2024). Fungal Microbiota Composition in Inflammatory Bowel Disease Patients: Characterization in Different Phenotypes and Correlation With Clinical Activity and Disease Course. Inflammatory Bowel Diseases, 30(7), 1164-1177. https://doi.org/10.1093/ibd/izad289

Vancouver

Catalán-Serra I, Thorsvik S, Beisvag V, Bruland T, Underhill D, Sandvik AK, et al. Fungal Microbiota Composition in Inflammatory Bowel Disease Patients: Characterization in Different Phenotypes and Correlation With Clinical Activity and Disease Course. Inflammatory Bowel Diseases. 2024;30(7):1164-1177. doi:10.1093/ibd/izad289

BibTeX
@article{CatalnSerra2024,
  author = {Catalán-Serra, Ignacio and Thorsvik, Silje and Beisvag, Vidar and Bruland, Torunn and Underhill, David and Sandvik, Arne Kristian and Granlund, Atle van Beelen},
  title = {Fungal Microbiota Composition in Inflammatory Bowel Disease Patients: Characterization in Different Phenotypes and Correlation With Clinical Activity and Disease Course},
  journal = {Inflammatory Bowel Diseases},
  year = {2024},
  volume = {30},
  number = {7},
  pages = {1164--1177},
  doi = {10.1093/ibd/izad289}
}
Kostenlos starten →